Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/198070
Full metadata record
DC FieldValueLanguage
dc.contributor.authorOriol-Tordera, Bruna-
dc.contributor.authorEsteve-Codina, Anna-
dc.contributor.authorBerdasco, María-
dc.contributor.authorGonçalves, Elena-
dc.contributor.authorEsteller, Manel-
dc.contributor.authorHanke, Tomá -
dc.contributor.authorMoltó, José-
dc.contributor.authorClotet, Bonaventura, 1953--
dc.contributor.authorCalle, María Luz-
dc.contributor.authorCombadiere, Behazine-
dc.contributor.authorSànchez, Àlex (Sànchez Pla)-
dc.contributor.authorMothe, Beatriz-
dc.contributor.authorRuiz-Riol, Marta-
dc.contributor.authorBrander, Christian-
dc.date.accessioned2023-05-16T14:18:12Z-
dc.date.available2023-05-16T14:18:12Z-
dc.date.issued2021-01-01-
dc.identifier.issn1758-2652-
dc.identifier.urihttp://hdl.handle.net/2445/198070-
dc.description.abstractBackground: BCN02 was a pilot kick-and-kill clinical trial that combined therapeutic vaccination (MVA.HIVconsv) with the latency reversing agent romidepsin (RMD) followed by a monitored antiretroviral pause (MAP) in 15 early-treated HIV+ individuals (NCT02616874). Out of 12 evaluable participants for an omics subanalysis, 8 participants showed early (pVL > 2000 copies/mL < 4 weeks) and 4 a more delayed viral rebound (pVL > 2000 copies/mL > 4 weeks) in MAP. Systems biology analyses identified epigenetic and molecular mechanisms associated with response to vaccination and RMD and viral rebound kinetics.-
dc.format.extent3 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherBioMed Central-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1002/jia2.25659-
dc.relation.ispartofJournal of the International AIDS Society, 2021, vol. 24, num. S1, p. 36-38-
dc.relation.urihttps://doi.org/10.1002/jia2.25659-
dc.rightscc-by (c) Oriol-Tordera, Bruna et al., 2021-
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/-
dc.sourceArticles publicats en revistes (Genètica, Microbiologia i Estadística)-
dc.subject.classificationVIH (Virus)-
dc.subject.classificationEpigenètica-
dc.subject.otherHIV (Viruses)-
dc.subject.otherEpigenetics-
dc.titleImpact of HIV kick-and-kill therapy on host epigenetic and transcriptional programs in PBMC, and viral rebound after cART interruption-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.identifier.idgrec720636-
dc.date.updated2023-05-16T14:18:12Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
Appears in Collections:Articles publicats en revistes (Genètica, Microbiologia i Estadística)

Files in This Item:
File Description SizeFormat 
720636.pdf62.92 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons